BioHybrid Solutions
Matthew Cummings has a background in analytical chemistry and organic chemistry. Previously serving as a Senior Scientist at Mylan, where Matthew developed analytical methods for drug substances and products. Matthew is currently the Sr. Director at BioHybrid Solutions, focusing on characterizing protein-polymer bioconjugates.
BioHybrid Solutions
BioHybrid Solutions LLC (BHS) is a Carnegie Mellon University spin-off, focused on next-generation protein-polymer biotherapeutics as alternatives to PEGylation. A fast-growing company with a network of committed partners and collaborators working to deliver the next generation of biotherapeutics.